Lupin 2024

February 19, 2024

You can read some of the February 19th print issue of Chain Drug Review in here. In CDR’s digital editions, you can find special sections and additional pages not posted online. You will need to register, but subscription is free!

Firework’s Cladek discusses digital store enhancements

Firework’s Cladek discusses digital store enhancements

NEW YORK — The Agile Innovation Series focuses on the need for organizations to constantly evolve and innovate with an agile mind-set to remain viable in today’s dynamic world. Throughout the series accelerate360’s Trey Holder explores the current business environment through interviews with leaders in a variety of fields. This month, Holder caught up with

Hallmark, Venmo continue to transform gift-giving

Hallmark, Venmo continue to transform gift-giving

KANSAS CITY — In 2024, Hallmark will continue to build on the popularity of Hallmark + Venmo Cards. These new cards offer a unique and convenient way of gifting to friends and family. “With this recently launched, first-of-its kind collaboration, customers can now securely send money with Venmo in a physical Hallmark card. By bringing

Proffitt on Dr. Reddy’s private label O-T-C business

Proffitt on Dr. Reddy’s private label O-T-C business

Lindsay Proffitt, who runs the private label over-the-counter drug business at Dr. Reddy’s, spoke with Chain Drug Review about her role, the significance of store brands for the company and the opportunities they present. CDR: What is your title and what are your responsibilities? PROFFITT: My title is head of private label O-T-C product management,

Staying consumer-centric in a digital world

Staying consumer-centric in a digital world

“The future is purchased by the present,” wrote Samuel Johnson in one of his essays for The Rambler. That idea was reflected during a panel discussion at last month’s FMI Midwinter Conference. Members of the group — which included David Best, president and chief operating officer of Coborn’s Inc.; Sandy Douglas, chief executive officer of

Key challenges in chemicals and materials R&D

Key challenges in chemicals and materials R&D

The chemical and materials industry contributes roughly $5.7 trillion to global GDP (gross domestic product) and supports an estimated 120 million jobs, according to a recent report published by the International Council of Chemical Associations. To meet massive demand, chemicals and materials research and development teams face many challenges, including the need to move at

PP_1170x120_10-25-21